Implant Sciences Corporation (OTCQB: IMSC) (PINKSHEETS: IMSC), a high technology supplier of systems and sensors for homeland security markets, announced today that its Quantum Sniffer(TM) QS-B220 bench-top explosives trace detector has passed all tests of the ASTM E2520-07 "Standard Practice for Verifying Minimum Acceptable Performance of Trace Explosive Detectors." The test confirms that the QS-B220 performs to the required standards of performance in the detection of trace amounts of explosives including TNT, RDX, and PETN. The tests were conducted by Cambridge Polymer Group, an independent laboratory. ASTM International, formerly known as the American Society for Testing and Materials (ASTM), is a globally recognized leader in the development and delivery of international voluntary consensus standards.
"The QS-B220's validation through this test brings it another step closer to commercial adoption in the US. Non-TSA security screeners and first responders can now purchase and deploy our bench-top explosives and narcotics trace detector in complete confidence that it is an effective technology," stated Glenn D. Bolduc, President and CEO of Implant Sciences. "We are confident in the performance of our QS-B220 and anticipate that this is the first of many detection standards around the world to which it will be successfully certified."
The QS-B220 had been engineered to meet the needs of a wide range of security applications. It has recently received CE Certification and is being evaluated by security organizations around the world.
Source: Implant Sciences Corp.
Date: Feb 6, 2012